Rafael Holdings, Inc. RFL
Biotechnology: Pharmaceutical Preparations · IPO 2018 · data as of November 13, 2026
Rafael Holdings, Inc. (RFL) is a healthcare company listed in the US with a market value of about $56M. In fiscal year 2026 it had revenue of $874000 and net income of -$30M, a net margin of -3390.7%.
Its overall Stock Analiz score is 1.0 out of 5 (weak). The strongest part is future growth (3/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of 2% a year, a 5-year average ROIC of -50%.
About Rafael
Rafael is listed in the US and classified in biotechnology: pharmaceutical preparations, IPO year 2018. Revenue went from $6M in 2016 to $874000 in 2026, a decline of about 16.9% a year. It was profitable in 1 of the last 10 years in our data. Its share count rose by 121% over three years (dilution for shareholders). It spends 2784% of revenue on research and development.
Score: 1.0 / 5
Checks passed
- 3-year revenue growth above 10% a year
- Profit margin improving
- Strong R&D investment or growth above 20%
- More cash than debt, or low debt to equity
- Liabilities below 60% of assets
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $874000 | $917000 | $637000 | $279000 | $410000 | $802000 | $5M | $5M | $4M | $6M |
| Net income | -$30M | -$31M | -$34M | -$2M | -$125M | -$23M | -$11M | -$5M | -$12M | $138000 |
| Free cash flow | -$30M | -$19M | -$8M | — | -$26M | -$16M | -$5M | -$4M | -$3M | -$3M |
| EPS (diluted) | $-0.58 | $-1.04 | $-1.45 | $-0.08 | $-6.31 | $-1.49 | $-0.66 | $-0.35 | $-0.93 | $0.01 |
| Net margin | -3390.7% | -3328.2% | -5401.9% | -672.4% | -30404.4% | -2875.4% | -219.0% | -95.2% | -266.5% | 2.5% |
| ROIC | -49.9% | -28.0% | -117.5% | -14.6% | -41.4% | -16.3% | -5.7% | -6.0% | -2.8% | 0.3% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Does Rafael pay a dividend?
Not currently.
Is Rafael a good stock to buy?
We do not give buy or sell advice. Rafael scores 1.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.